Palatin Technologies, Inc. PTN PHARMA

Q: What is the current share price of Palatin Technologies, Inc. (PTN)?

As of 2026-09-19 21:16 PDT, Palatin Technologies, Inc. (PTN) trades at $12.68 on NasdaqCM. Its 52-week range is $5.45 to $28.00.

Q: What is the market capitalisation of PTN?

Palatin Technologies, Inc. (PTN) has a market capitalisation of $22.56M on NasdaqCM.

Q: What is the P/E ratio of PTN?

PTN trades at a trailing price-to-earnings (P/E) ratio of 115.27. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 1.82.

Q: Is PTN a good stock to buy?

This page provides a data-driven analysis of Palatin Technologies, Inc. (PTN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Healthcare · Biotechnology · United States

https://palatin.com

Company Profile ↓

$12.68

+126.43% 1Y

Mkt Cap$22.56M

P/E115.27

P/B1.82

52W High$28.00

52W Low$5.45

Book Value$5.96

EPS (TTM)$0.11

Company Overview

Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.

Recent Developments

Trailing 12 Months Year-on-year growth — revenue -100.0%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	-
1 Year:	-100.00%

Stock Price Performance

1 Year:	+126.43%
6 Months:	-44.77%
3 Months:	-10.20%
1 Month:	+63.19%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Mixed

52-Week Range 32% of range

$5.45 $28.00

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMABelow
RSI (14)68.31 · Neutral

Price Performance

1M+63.19%

3M-10.20%

6M-44.77%

1Y+126.43%

Valuation vs Sector

P/E of 115.27 is above the sector median of 24.83 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

Trading at a high P/E of 115.3.
Trading 54.7% below its 52-week high.
In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

115.27

Industry PE

24.83

Forward P/E

-5.22

PEG Ratio

1.62

Book Value

$5.96

Price to Book

1.82

P/S

1.50

EV/EBITDA

-1.03

Dividend Yield

0.00%

Growth (CAGR)

Revenue 5Y

Profit 5Y

Revenue (YoY)

-100.00%

Earnings (YoY)

Profitability & Returns

ROCE

ROE

ROA

-65.26%

Profit Margin

-48.50%

Op Margin

-40.33%

Gross Margin

4.28%

EPS (Latest Qtr)

$-0.37

EPS (TTM)

$0.11

Balance Sheet & Liquidity

Debt/Equity

2.71

Quick Ratio

4.86

Current Ratio

5.04

Debt

$286.66K

Total Assets

$13.23M

Current Assets

$12.79M

Working Capital

$-5.09M

Ownership

Promoter Holding

7.86%

Chg in Prom Hold

0.00%

FII / Inst Holding

50.16%

Chg in FII Hold

-0.57%

Financial Snapshot

Enterprise Value

$22.56M

Total Revenue (TTM)

$12.88M

EBITDA

$-8.75M

Free Cash Flow

$-13.67M

Operating Cash Flow

$-14.93M

Shares Outstanding

1.78M

Gross Margin

4.28%

Payout Ratio

0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	PTN Palatin Technologies, Inc. PHARMA	12.68	115.27	$22.56M	0.00%	-	-	-	-
2	LLY Eli Lilly and Company SPXR3KPHARMA	1,123.91	37.80	$1.00T	0.60%	-	102.29%	7.20%	11.41%
3	JNJ Johnson & Johnson SPXR3KPHARMA	269.12	31.22	$648.55B	1.98%	14.88%	25.74%	2.43%	4.76%
4	ABBV AbbVie Inc. SPXR3KPHARMA	248.78	70.48	$439.62B	2.78%	10.47%	-129.24%	1.75%	-29.06%
5	MRK Merck & Co., Inc. SPXR3KPHARMA	148.46	118.77	$366.28B	2.31%	-	6.96%	5.64%	10.01%
6	UNH UnitedHealth Group Incorporated SPXR3KPHARMA	400.84	25.74	$359.79B	2.47%	9.74%	14.15%	10.40%	5.43%
7	NVS Novartis AG PHARMA	137.70	20.80	$261.73B	3.36%	21.09%	30.35%	9.25%	26.22%
8	AZN AstraZeneca PLC NDXPHARMA	160.04	23.99	$248.20B	2.00%	15.97%	21.96%	9.82%	45.96%
9	TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA	603.02	32.49	$222.97B	0.29%	8.14%	13.51%	8.81%	12.95%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Jun 2015	Sep 2015	Dec 2015	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Sep 2021	Dec 2021	Mar 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	8.85M	116.04K	3.92M
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.23M	4.60M	4.19M	7.44M	5.50M
Operating Income	-	-11.80M	-12.63M	-12.09M	-	-12.44M	-9.44M	-3.01M	-	11.23M	2.94M	-517.44K	-	-5.63M	-5.05M	-5.76M	-	-4.86M	-5.64M	-5.71M	-	-3.95M	-9.25M	-6.49M	-7.22M	-8.45M	-7.82M	-8.75M	-5.59M	-7.30M	-6.11M	1.17M	-9.22M	-7.76M	-	-5.23M	-4.60M	4.66M	-7.33M	-1.58M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4.76M	-2.17M	4.69M	-7.25M	-1.41M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.79K	3.49K	2.00K	498	1.27K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4.81M	-2.23M	4.68M	-7.26M	-1.43M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-12.09K	-12.41K	-13.25K	-12.70K	-13.36K	-13.05K	-10.03K	-3.56K	13.31K	10.60K	3.03K	-739	11.81K	-5.68M	-5.04M	-5.73M	52.22M	-4.50M	-5.24M	-5.38M	-7.30M	-3.94M	-9.99M	-5.73M	-7.11M	-8.69M	-7.63M	-8.26M	2.71M	-8.67M	-5.21M	-7.84M	-8.44M	-7.82M	-	-4.81M	-2.23M	4.68M	-7.26M	-1.43M
Diluted EPS	-0.09	-0.08	-0.08	-	-	-0.08	-0.06	-0.02	0.07	0.05	0.01	0.00	0.06	-0.03	-0.02	-0.03	0.23	-0.02	-0.02	-0.02	-0.03	-	-	-	-	-	-	-	-	-	-	-	-0.53	-19.71	-5.92	-9.13	-	4.26	-2.86	-0.37
R&D Expense	-	10.60M	11.27M	10.68M	-	11.23M	8.13M	9.06M	-	14.16M	6.05M	7.07M	-	3.62M	2.96M	3.94M	-	3.13M	3.26M	3.64M	-	2.92M	4.01M	2.51M	3.48M	5.43M	4.98M	6.03M	4.37M	4.83M	5.01M	5.55M	7.16M	5.74M	3.43M	3.76M	-	2.53M	4.32M	3.52M

Profit & Loss (Annual)

Figures in USD.

Metric	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Revenue	14.18M	1.48M	73.74K	10.36K	-	-	0	67.13M	67.13M	60.30M	117.99K	-188.60K	1.47M	4.85M	4.49M	0
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	217.53K	418.47K	97.64K	0
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	1.25M	4.44M	4.39M	0
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	37.84M	37.92M	34.67M	22.71M
Operating Income	-3.01M	-13.65M	-18.79M	-15.59M	-15.79M	-17.29M	-49.25M	25.93M	25.93M	35.74M	-23.61M	-33.38M	-36.59M	-33.49M	-30.28M	-22.71M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-36.04M	-28.40M	-29.38M	-17.03M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	29.68K	20.01K	17.11K	15.03K
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-36.20M	-28.71M	-29.74M	-17.31M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	0	-4.67M	0	-
Net Income	-1.79M	-12.82M	-17.25M	-20.86M	-13.93M	-17.67M	-51.71M	24.70M	24.70M	35.77M	-22.43M	-33.60M	-36.20M	-24.04M	-29.74M	-17.31M
Diluted EPS	-	-	-	-	-	-	-0.33	0.12	0.12	0.16	-0.10	-	-189.50	-110.50	-101.16	-32.15
R&D Expense	12.29M	10.38M	13.81M	10.53M	10.83M	24.56M	43.07M	32.57M	32.57M	14.86M	13.96M	12.93M	21.33M	22.63M	22.40M	14.90M

Balance Sheet (Annual)

Figures in USD.

Metric	Jun 2009	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Assets	-	-	21.17M	5.38M	25.07M	12.56M	29.47M	10.86M	56.83M	39.02M	104.74M	85.05M	67.30M	36.07M	17.94M	10.74M	3.27M
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	34.60M	16.32M	9.77M	2.92M
Cash & Equivalents	4.38M	5.41M	18.87M	3.83M	19.17M	12.18M	27.30M	8.00M	40.20M	38.00M	43.51M	82.85M	60.10M	29.94M	7.99M	9.53M	2.56M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	944.47K	526.00K	0	-
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	1.78M	2.92M	0	-
Total Liabilities	-	-	2.98M	3.55M	2.10M	2.77M	17.27M	28.44M	62.00M	12.05M	4.19M	4.88M	17.65M	19.80M	19.92M	10.85M	8.04M
Current Liabilities	-	-	2.81M	3.46M	2.06M	2.77M	7.36M	13.88M	54.96M	10.76M	4.19M	3.93M	10.51M	16.26M	15.13M	9.66M	8.01M
Long Term Debt	-	-	-	-	-	0	9.78M	14.11M	6.28M	332.90K	332.90K	-	-	-	-	-	-
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	1.15M	1.05M	590.34K	163.78K
Total Equity	3.31M	9.32M	18.19M	1.83M	22.98M	9.79M	12.20M	-17.59M	-5.16M	26.96M	100.55M	80.17M	49.65M	16.27M	-1.98M	-111.50K	-4.78M
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	185.42K	233.13K	358.53K	929.60K

Cash Flows (Annual)

Figures in USD.

Metric	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Operating Cash Flow	-5.73M	-11.03M	-15.49M	-13.65M	-12.21M	-13.36M	-47.36M	12.88M	1.70M	-21.78M	41.33M	-93.64K	-29.92M	-29.27M	-31.46M	-21.31M
Investing Cash Flow	38.01K	3.45M	479.38K	-5.30M	5.24M	0	-1.40M	991.60K	227.55K	-36.14K	-62.88K	-5.72K	-261.37K	-3.43M	12.45M	3.13M
Financing Cash Flow	6.72M	21.05M	-34.92K	34.29M	-18.79K	28.47M	29.47M	18.32M	-4.13M	27.33M	-1.92M	-22.65M	18.36K	10.75M	20.55M	11.21M
Capital Expenditure	-7.00K	-	-0	-59.61K	-6.24K	-0	-17.70K	-133.40K	-22.45K	-36.14K	-62.88K	-5.72K	-261.37K	-433.93K	-42.53K	-
Free Cash Flow	-5.74M	-	-15.49M	-13.71M	-12.21M	-13.36M	-47.38M	12.75M	1.68M	-21.82M	41.26M	-99.36K	-30.18M	-29.71M	-31.50M	-21.31M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-30.17M	-21.95M	1.54M	-6.96M

Ratios (Annual)

Figures in %.

Metric	Jun 2010	Jun 2011	Jun 2012	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	85.2%	91.4%	97.8%	-
Operating Margin %	-21.3%	-925.4%	-25,476.5%	-150,421.4%	-	-	-	38.6%	38.6%	59.3%	-20,007.6%	17,701.3%	-2,491.6%	-689.9%	-674.3%	-
Net Margin %	-12.6%	-868.6%	-23,398.6%	-201,352.9%	-	-	-	36.8%	36.8%	59.3%	-19,006.9%	17,813.9%	-2,465.1%	-495.2%	-662.3%	-
ROE %	-19.2%	-70.4%	-942.3%	-90.8%	-142.3%	-144.7%	294.1%	-478.3%	91.6%	35.6%	-28.0%	-67.7%	-222.5%	1,214.1%	26,669.9%	362.3%
ROCE %	-	-74.3%	-976.6%	-67.7%	-161.3%	-78.2%	1,627.6%	1,385.7%	91.8%	35.5%	-29.1%	-58.8%	-184.7%	-1,192.7%	-2,791.7%	478.8%

Shareholding Pattern

Insiders

7.86%

Institutions

50.16%

Public Float

54.44%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Driehaus Capital Management, LLC	17.13%	166.71K	$1.81M
2	Jupiter Topco LLC	14.38%	140.00K	$1.52M
3	Logos Global Management LP	13.36%	130.00K	$1.41M
4	RA Capital Management, L.P.	6.38%	62.12K	$674.67K
5	Balyasny Asset Management LP	4.22%	41.11K	$446.45K
6	Morgan Stanley	2.80%	27.27K	$296.17K
7	Opaleye Management Inc.	2.11%	20.50K	$222.63K
8	Geode Capital Management, LLC	1.99%	19.38K	$210.49K
9	Vanguard Capital Management LLC	1.94%	18.91K	$205.37K
10	Miller Financial Services LLC	1.54%	15.00K	$162.90K

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for PTN

Google News ue, 08 Sep 2026

Palatin Technologies, Inc. Common Stock (Backpack Securities) Price - Bybit

<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxOdmRwU1dDV2VBc3BiYU10SXlNcDktYjZzWXJGeE1hOEJKSHEwT2twcDdVdjdiOUdSWDZoZzlPYzFWdThKSDBGUUxSWS1XVXRkS0k5MXF3ay1NLXN6QmdjOV9EX1ZMZ0NpdEN5MUxZWGtUbF9KOEhNMkkwa1BOX3RiNE1KMzRrVy0wcG9RaF…

Google News Fri, 29 May 2026

PTN Stock Price and Chart — NASDAQ:PTN - tradingview.com

<a href="https://news.google.com/rss/articles/CBMiW0FVX3lxTE1uYkNzQVBUZDZOdjNnbXpQUW51bUtaLTg5cFExT2czS2xKZkxkVm5EcWkzR1BFOGlrbFlBb3NjVFJWbU54MTdWX2hWT3dsZ01nRGVXSlN3aHpvNXc?oc=5" target="_blank">PTN Stock Price and Chart — NASDAQ:PTN</a>&n…

Google News Mon, 18 May 2026

Palatin to Begin Trading on Nasdaq Stock Exchange - PR Newswire

<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxOcV9xazhvWlI5ekxrNFBrSVZrN3lPOWRSLUlLY3ZVZjNFTU5kR3pOZ0tiQVp2YlZ2RUFKVml5Q2hMYzAzRUNHdjV0QkU5Xy1LWmJNWEExZDVQSklhME1zeDVmbDF3enQ0ZGxCV0FhX0VPWXRFV1BBUHAzM1ZGV29IQXBQajZJa21KWDZwZU…

Google News Fri, 04 Sep 2026

Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - kalkine.com.au

<a href="https://news.google.com/rss/articles/CBMiVEFVX3lxTFBadUw3Z0lndkFINjc0bFdPdDhJbVVlbWlpR19fNThKcjVic1JQeVNVcThPWkxsTnJuZmVWWXhGaG1xMl9oNUFSNDFYQ0JnNEdGakN6dA?oc=5" target="_blank">Palatin Technologies, Inc. Common Stock (NASDAQ: PTN)…

Google News Fri, 14 Aug 2026

Palatin Technologies (PTN) gains 4.7% stake holder AuGC BioFund in 13G/A - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiygFBVV95cUxQdkVENUVIWnF3Nmo1QWZ0a3F1NVVETldfU080TWpxcWx6T1lTQk1SWWlta3VPUUhvUnFYSWhRZlFscC1KQkFkbmJsS1JzN2gybnVvMXFCaC1FOEk1VENGM1hscnFNd1NtdXJHLW1qWExMWnNtdG1wWnRDdHhjVWpRX29HRjJBMzRZdkxNRl…

Google News ue, 26 May 2026

PTN - Palatin Technologies Inc Stock Price and Quote - Finviz

<a href="https://news.google.com/rss/articles/CBMiREFVX3lxTE13YWJ2N0E1RkRLOGxxYWpmV1NZWkpiN2liWUozZVYtdmpIYnJlOFZsczl2TnE5N3Q1cGllWWdrY1RPUmVJ?oc=5" target="_blank">PTN - Palatin Technologies Inc Stock Price and Quote</a>  <font c…

PTN — Frequently Asked Questions

What is the current share price of Palatin Technologies, Inc. (PTN)?

As of 2026-09-19 21:16 PDT, Palatin Technologies, Inc. (PTN) trades at $12.68 on NasdaqCM. Its 52-week range is $5.45 to $28.00.

What is the market capitalisation of PTN?

Palatin Technologies, Inc. (PTN) has a market capitalisation of $22.56M on NasdaqCM.

What is the P/E ratio of PTN?

PTN trades at a trailing price-to-earnings (P/E) ratio of 115.27. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 1.82.

Is PTN a good stock to buy?

This page provides a data-driven analysis of Palatin Technologies, Inc. (PTN), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Palatin Technologies, Inc. PTN PHARMA

Company Overview

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Palatin Technologies, Inc. Common Stock (Backpack Securities) Price - Bybit

PTN Stock Price and Chart — NASDAQ:PTN - tradingview.com

Palatin to Begin Trading on Nasdaq Stock Exchange - PR Newswire

Palatin Technologies, Inc. Common Stock (NASDAQ: PTN) Share Price, PTN Stock News, PTN Share Price & Updates - kalkine.com.au

Palatin Technologies (PTN) gains 4.7% stake holder AuGC BioFund in 13G/A - Stock Titan

PTN - Palatin Technologies Inc Stock Price and Quote - Finviz

PTN — Frequently Asked Questions

What is the current share price of Palatin Technologies, Inc. (PTN)?

What is the market capitalisation of PTN?

What is the P/E ratio of PTN?

Is PTN a good stock to buy?

Explore More